Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept-Reference-Cited by-同舟云学术

Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept

Published:2020-01-01 Issue:1 Volume:37 Page:585-591
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Sgarbura Olivia¹²^ORCID,Al Hosni Mohammed³,Petruzziello Andrea⁴,Figueroa Rodrigo⁵,Khellaf Lakhdar²⁶^ORCID,Pissas Marie-Hélène¹²,Carrère Sébastien¹²,Nougaret Stephanie²⁷^ORCID,Bibeau Frédéric⁸,Quénet François¹²^ORCID

Affiliation:

1. Surgical Oncology Department, Montpellier Cancer Institute, University of Montpellier, Montpellier, France

2. University of Medicine Montpellier 2 Rue de l’École de Médecine, Montpellier, France

3. Surgical Oncology Division, Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman

4. Marcelino Champagnat Hospital, Curitiba, Brazil

5. Sanatorio Allende, Cordoba, Argentina

6. Pathology Department, Montpellier Cancer Institute, University of Montpellier, Montpellier, France

7. Radiology Department, Montpellier Cancer Institute, University of Montpellier, Montpellier, France

8. Pathology Department, Caen University Hospital, University of Caen Normandy, Caen, France

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2020.1772511

Reference25 articles.

1. Pseudomyxoma peritonei: natural history and treatment

2. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin

3. Long-Term Survival in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: 10 Years of Experience from a Single Institution

4. Secondary Cytoreduction and Perioperative Intraperitoneal Chemotherapy after Initial Debulking of Pseudomyxoma Peritonei: A Study of Timing and the Impact of Malignant Dedifferentiation

5. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-stage cytoreductive surgery for ‘extensive’ pseudomyxoma peritonei: A legitimate alternative or salvage strategy?;European Journal of Surgical Oncology;2024-10

2. New insights in the management of pseudomyxoma peritonei;Journal of Surgical Oncology;2024-08-29

3. Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC);Innovative Surgical Sciences;2024-03-01

4. Perioperative outcomes of cytoreductive surgery for tumours of colorectal or appendiceal origin with ovarian involvement;Journal of Surgical Oncology;2023-03-21

5. Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival;Cancers;2022-09-13